• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $MC

    Moelis & Company

    Subscribe to $MC
    $MC
    Investment Managers
    Finance

    Moelis & Company operates as an investment banking advisory firm in the United States, Europe, and internationally. It offers advisory services in the areas of mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. The company offers its services to public multinational corporations, middle market private companies, financial sponsors, entrepreneurs, and governments. It has strategic alliances with Sumitomo Mitsui Banking Corporation and SMBC Nikko Securities Inc.; and Alfaro, Dávila y Scherer, S.C. The company was founded in 2007 and is headquartered in New York, New York.

    IPO Year: 2014

    Exchange: NYSE

    Website: moelis.com

    Peers

    $EVR
    $GHL

    Recent Analyst Ratings for Moelis & Company

    DatePrice TargetRatingAnalyst
    3/13/2025$100.00 → $70.00Overweight → Underweight
    Morgan Stanley
    12/20/2024$71.00 → $86.00Mkt Perform → Outperform
    Keefe Bruyette
    12/9/2024$66.00 → $92.00Underweight → Overweight
    Morgan Stanley
    9/12/2024$70.00Equal Weight
    Wells Fargo
    3/13/2024$53.00 → $58.00Sell → Neutral
    Goldman
    1/29/2024$56.00Mkt Perform
    Keefe Bruyette
    1/11/2023$40.00 → $37.00Neutral → Sell
    Goldman
    11/3/2022$40.00 → $37.00Mkt Perform → Underperform
    Keefe Bruyette
    9/23/2022$43.00 → $35.00Neutral → Sell
    UBS
    7/18/2022$53.00 → $36.00Equal-Weight → Underweight
    Morgan Stanley
    See more ratings